Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Oct 25
 -0.02 / -0.03%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 109.50, with a high estimate of 155.00 and a low estimate of 75.00. The median estimate represents a +39.12% increase from the last price of 78.71.

Analyst Recommendations

The current consensus among 24 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -20.93%
Growthannually 174.05%


Growthquarterly -3.03%
Growthannually 64.89%
Key to the earnings and sales forecast charts.